CAS: 254740-64-2 - 4'-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-N-(4,5-dimethyl-3-isoxazolyl)-2'-(ethoxymethyl)-[1,1'-biphenyl]-2-sulfonamide
Sparsentan (RE-021)
CAS:254740-64-2
Formula:
C32H40N4O5S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
592.7488
Ref: IN-DA00C2P2
1g | 601.00 € | ||
5g | To inquire | ||
25mg | 192.00 € | ||
100mg | 214.00 € | ||
250mg | 320.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Sparsentan-d5 (RE-021-d5)
Formula:
C32H35D5N4O5S
Color and Shape:
Off-White Solid
Molecular weight:
597.79
Ref: 4Z-S-059001
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Sparsentan (RE-021)
CAS:254740-64-2
Formula:
C32H40N4O5S
Color and Shape:
White To Off-White Solid
Molecular weight:
592.76
Ref: 4Z-S-059002
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Sparsentan
CAS:254740-64-2
Sparsentan (DARA-a) is a first-in-class orally active and highly potent dual endothelin A and angiotensin …
Formula:
C32H40N4O5S
Purity:
97.94% - 98.75%
Color and Shape:
Solid
Molecular weight:
592.75
Ref: TM-T5355
2mg | 39.00 € | ||
5mg | 57.00 € | ||
10mg | 92.00 € | ||
25mg | 165.00 € | ||
50mg | 252.00 € | ||
100mg | 370.00 € | ||
200mg | 525.00 € | ||
1mL*10mM (DMSO) | 75.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
RE 201
Controlled ProductCAS:254740-64-2
Formula:
C32H40N4O5S
Color and Shape:
Neat
Molecular weight:
592.749
Ref: TR-R129300
100mg | 27,348.00 € |
Estimated delivery in United States, on Friday 21 Feb 2025
RE-021-d9
Controlled ProductCAS:254740-64-2
Applications Isotope labelled RE 201 is used an Endothelin A receptor antagonist used in the …
Formula:
C32D9H31N4O5S
Color and Shape:
Neat
Molecular weight:
601.804
Ref: TR-R129302
25mg | 13,475.00 € |
Estimated delivery in United States, on Friday 21 Feb 2025
Sparsentan (PS-433540,RE-021,DARA)
CAS:254740-64-2
Sparsentan is an investigational drug that acts as a selective, orally available, small-molecule inhibitor of …
Formula:
C32H40N4O5S
Purity:
Min. 95%
Molecular weight:
592.75 g/mol
Ref: 3D-EKA74064
1mg | Discontinued | Request information | |
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information |